Back

Effect of hypertrophy degree and fibrosis on regional contractile function in left ventricular hypertrophy

2 May 2019 (08:30 - 17:00)
Organised by:
Congress Presentation Part of: Poster session 1 Deformation Imaging EACVI Premium Access EuroCMR 2019

About the speaker

Photo
Doctor Natalia Cobo Gomez

UNIVERSITY HOSPITAL VIRGEN DE VALME, Seville (Spain)

54 More presentations in this session

Presentation thumbnail
Prognostic value of cardiac magnetic resonance in systemic sclerosis
Doctor A. Pepe (Pisa, IT)
Abstract Slides
Presentation thumbnail
Fast-SENC segmental intramyocardial strain quantifies subclinical myocardial dysfunction
Doctor M. Montenbruck (Hamburg, DE)
Abstract
Presentation thumbnail
Feature tracking by cardiovascular magnetic resonance: left ventricular dysfunction predicts outcome in heart failure with preserved ejection fraction
Doctor A. Kammerlander (Vienna, AT)
Abstract
Presentation thumbnail
Fast-SENC quantifies right ventricular intramyocardial strain to assess subclinical RV dysfunction
Doctor M. Montenbruck (Hamburg, DE)
Abstract
Presentation thumbnail
Same-day CMR and pre-operative predictive simulation of Fontan pulmonary blood flow
Doctor P. Frieberg (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1

The Event

Event poster

EuroCMR 2019

2 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Genetics, patterns of hypertrophy and fibrosis on myocardial mechanics in hypertrophic cardiomyopathy
10 May 2023
thumbnail
Congress Presentation
Regional distribution of diffuse fibrosis in the basal and mid-ventricular AHA segments in patients with type 2 diabetes
1 September 2024
thumbnail
Webinar
Left Atrial Dysfunction
21 October 2022
thumbnail
Congress Presentation
Relationship of myocardial fibrosis markers with cardiac structural and functional parameters in patients with post-myocardial infarction.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources